Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F20JP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,331
Award facts
- Contract value 100% obligated
- $51,331.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $51,331.26 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of Ibrance 125 mg capsules in quantities of 21. This firm fixed-price delivery order is scheduled for completion by January 29, 2026, with performance at the awardee's Conshohocken, Pennsylvania facility. The contract was awarded competitively with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military treatment facilities. The IDC encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. Ibrance (palbociclib) is a prescription oncology medication used in the treatment of certain breast cancers, reflecting the contractor's role in supplying essential pharmaceutical products to the federal healthcare system.
Quick answers
Who was awarded contract SPE2DR26F20JP?
SPE2DR26F20JP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F20JP worth?
The government has obligated $51,331 on SPE2DR26F20JP.
Is contract SPE2DR26F20JP an order under another contract?
Yes. SPE2DR26F20JP is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20JP competed?
The extent of competition for SPE2DR26F20JP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award